Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0650
-0.0020 (-2.99%)
Sep 18, 2026, 1:54 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 20.58 million as of September 17, 2026. Its market cap has decreased by -20.86% in one year.
Market Cap
20.58M
Enterprise Value
24.86M
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 20.58M, an increase of 48.02%. That is a compound annual growth rate of 3.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 20.58M | -24.26% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 36.04M |
| Radiopharm Theranostics | 34.70M |
| Patrys | 23.33M |
| Imugene | 23.02M |
| NeuroScientific Biopharmaceuticals | 22.99M |
| Argenica Therapeutics | 22.48M |
| Proteomics International Laboratories | 22.33M |
| EZZ Life Science Holdings | 20.47M |